Home Topics T3 Pharmaceuticals AG

Tag: T3 Pharmaceuticals AG

Qualified for the “BaseLaunch” funding program: Marlise Amstutz, Simon Ittig and Christoph Kasper of T3 Pharmaceuticals

New therapeutic approach for cancer inspired by nature

By genetically modifying bacteria, a new startup from the University of Basel known T3 Pharmaceuticals AG want to develop new cancer therapies. Scientists actually took inspiration from nature...